MEH, Inc.

Hazelwood, MO ManufacturingNAICS 325410

Self-funded health planPlan year 2024Renews January
2,510ParticipantsFirst year on file
$6.0MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#9 of 46Manufacturing in MOBy participants

Overview

MEH, Inc. sponsors a self-funded health plan that covered 2,510 participants in plan year 2024. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
2,510
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
The Mallinckrodt Pharmaceuticals Welfare Benefit Plan, plan 501 (2,510 participants); The Mallinckrodt Pharmaceuticals Retiree Welfare Benefit Plan, plan 502 (451 participants)
Broker compensation
$79K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Hartford Life and AccidentLife, Accidental Death and Dismemberment3,607$2.1M$43K
Life Insurance Company of North AmericaLong-term disability, Short-term disability2,476$1.1M$22K
Vision Service PlanVision1,968$500K—
Cigna Life Insurance Co. of New YorkShort-term disability547$250K$6K
United Healthcare Services, Inc.Employee Assistance Program2,510$53K—
Ace American Insurance CompanyBusiness Travel Accident2,738$43K$9K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$6.0M/ year

Estimated prescription spend: 2,510 participants × $2,371 national average per member. Usually higher once dependents are counted.

$155K–$381K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$45K–$113K
Lower-cost therapeutic alternatives$66K–$138K
Generic pricing vs. actual cost$29K–$86K
PBM contract terms$15K–$45K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2024
Plan sponsor
MEH, Inc.
Sponsor EIN
65-0952696
Plan numbers
501, 502
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 65-0952696 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan
Type
401(k) plan
Participants
4,280

About this data

Source: MEH, Inc.'s Form 5500 filing for plan year 2024 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with MEH, Inc..

Request a correction · Methodology